Not all progestins are created equal — and the differences matter for your patients. Dr. Tami Rowen brings her expertise in sexual medicine, menopause, and complex gynecologic care to break down the evolving progestogen landscape and its implications for your prescribing practice.

This clinician education session with Mitchell Clark, MD, MPH, examines the current evidence surrounding ovarian cancer screening. The discussion reviews population-level data, screening limitations, risk stratification, and guideline recommendations, with a focus on applying evidence to patient counseling and shared decision-making in clinical practice.

This clinician education session with Anjali Malik, MD, reviews the current state of mammography for breast cancer screening in 2026. The discussion addresses evolving screening guidelines, advances in imaging technology, breast density considerations, and ongoing areas of clinical debate to support evidence-based screening and patient counseling.

This clinician education session with Angela Fitch, MD, FACP, FOMA, provides an up-to-date review of GLP-1–based therapies, including injectable and oral options and agents in the development pipeline. The discussion covers mechanisms of action, efficacy and safety data, clinical indications, and practical considerations for prescribing and patient counseling.

Jennifer Lanoff, WHNP-BC, MSCP, presents a clinician framework for identifying the Pelvic Pain Pentad — endometriosis, MCAS, POTS, hEDS, and pelvic venous disease — and the overlapping presentations that make this constellation so frequently missed.

Dr. Suzanne Gilberg-Lenz — board-certified OB/GYN, integrative medicine specialist, and author of Menopause Bootcamp — delivers an evidence-based review of botanical therapies in midlife, with practical guidance for clinical practice.

Dr. Lisa Chacko, founder of Curate Medical and architect of the "menopause-informed care" framework, examines the forces reshaping menopause care delivery — and what clinicians need to know to stay ahead of them.

This clinician education session with Dr. Candace Westgate reviews the evolving landscape of multi-cancer early detection (MCED) testing beyond Galleri. The discussion examines emerging assays, underlying science, current evidence, and practical considerations for patient selection, test interpretation, limitations, and ethical implications in clinical practice.

The gut microbiome plays a surprising and significant role in women's hormonal health — and its connection to menopause is an area of rapidly growing research. In this HERtalks event, pharmacist and microbiome specialist Dragana Skokovic-Sunjic breaks down what the current evidence tells us and what it means for women navigating the menopausal transition.

In honor of Memorial Day, HERmedicine's Monday Night Discussion will not meet on May 26th. We'll be back the following week with more women's health education. Wishing our community a meaningful and restful holiday.

This clinician education session with Susan Brian, MD examines metabolic disease in midlife, with a focus on diabetes, insulin resistance, and cardiometabolic risk. The discussion reviews key metabolic changes, risk assessment, and evidence-based management strategies to support patient-centered care during midlife.

Ductal carcinoma in situ is evolving rapidly — and so is the evidence guiding its management. In this CME session, Dr. Laura Esserman provides a current, evidence-based review of DCIS diagnosis, risk stratification, and treatment, including emerging data on active surveillance and the growing movement away from overtreatment.

Abnormal uterine bleeding in perimenopausal and menopausal women is a common but clinically complex presentation. In this session, Dr. Steven Goldstein offers a systematic, evidence-based framework for evaluation — covering imaging, endometrial sampling, and the clinical decision points that guide management.

Perimenopause begins earlier than most clinicians and patients realize — and the evidence is reshaping how we define and respond to it. In this session, Dr. Marcie Richardson reviews the science of perimenopause onset, including the Late Reproductive Stage, and offers practical strategies for identifying and supporting women earlier in the transition.

GLP-1 receptor agonists have transformed Type 2 diabetes care — but they are not the only tool available. In this session, Dr. Jyothi Joseph-Hayes provides a practical, evidence-based review of the full range of diabetes medications beyond GLP-1s, helping clinicians make more individualized treatment decisions for their patients.

The WISDOM Study has enrolled more than 80,000 women to compare annual mammography with personalized, risk-based breast cancer screening — and the Phase 1 results are practice-changing. In this session, Allison Fiscalini presents the latest findings and what they mean for clinical screening guidelines and shared decision-making.

Not every menopause patient fits the guidelines — and those are often the most important patients to get right. Dr. Risa Kagan, one of the country's leading menopause specialists, uses a case-based format to work through complex clinical scenarios and sharpen decision-making beyond the standard of care.

Adolescent gynecology demands specialized skills and a trauma-informed lens. In this clinician-focused session, Dr. Leslie Appiah shares evidence-based tools for evaluation, referral, and building trust with young patients and their families.